What is the ticker symbol for Jounce Therapeutics?

Jounce Therapeutics trades under the ticker JNCE on NASDAQ.

What sector does Jounce Therapeutics operate in?

Jounce Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze JNCE in a portfolio?

PortView shows JNCE's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Jounce Therapeutics (JNCE) Stock Analysis

NASDAQHealthcareBiotechnology

$1.88+0.00%

1-year price historyRange $0.64 – $5.49

52-week range$1.88

$0.58$5.37

What Jounce Therapeutics does

Jounce Therapeutics, Inc. is an immunotherapy firm currently in the clinical development phase, dedicated to discovering and advancing new cancer treatments. A key asset in its pipeline is vopratelimab, a monoclonal antibody presently in Phase II clinical trials. This therapeutic agent functions by binding to and activating the Inducible T cell CO-Stimulator (ICOS), a specific protein located on the surface of T cells within various solid tumors. The company is also progressing JTX-8064, an antibody designed to target leukocyte immunoglobulin like receptor B2 (LILRB2), a cell surface receptor found on macrophages. Additionally, JTX-1484 is under development, focusing on myeloid targets. Completing its innovative portfolio is JTX-1811, an anti-CCR8 monoclonal antibody precisely engineered to selectively reduce the presence of intra-tumoral T regulatory cells within the tumor's microenvironment. Jounce Therapeutics, Inc. was founded in 2012 and maintains its primary operational base in Cambridge, Massachusetts.

Key metrics

Market cap

$98.95M

P/E (TTM)

-1.96

EPS (TTM)

$-0.96

Beta

0.75

Dividend yield

0.00%

Revenue / share

$1.59

50-day avg

$1.64

200-day avg

$1.93

52-week high

$5.37

52-week low

$0.58

CEO

Kimberlee Cobleigh Drapkin CPA

ETFs linked to JNCE

Broad-market and Healthcare sector ETFs an investor holding Jounce Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how JNCE fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze JNCE in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Jounce Therapeutics?: Jounce Therapeutics trades under the ticker JNCE on NASDAQ.
Which exchange is JNCE listed on?: JNCE is listed on NASDAQ.
What sector does Jounce Therapeutics operate in?: Jounce Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze JNCE in a portfolio?: PortView shows JNCE's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.